4.7 Article

Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches A Randomized Clinical Trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention

Messoud Ashina et al.

Summary: AMG 301 showed no benefit over placebo for migraine prevention in this study, suggesting further research is needed to understand the role of PACAP isoforms and its receptors in migraine pathophysiology.

CEPHALALGIA (2021)

Review Clinical Neurology

Nocebo response in human models of migraine: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without aura and healthy volunteers

Hashmat Ghanizada et al.

Summary: Human models of migraine have been used for three decades to test trigger molecules, but the nocebo effects have not been systematically explored. A systematic review and meta-analysis showed a low nocebo response rate in randomised clinical trials using human models of migraine.

CEPHALALGIA (2021)

Review Medicine, General & Internal

Migraine: disease characterisation, biomarkers, and precision medicine

Messoud Ashina et al.

Summary: The paper discusses the progress made in the search for biomarkers of migraine within genetics, provocation modeling, biochemistry, and neuroimaging research. Challenges and future directions for each biomarker modality are outlined, as well as advances in combining and integrating data from multiple biomarker modalities. These efforts contribute to developing precision medicine for future patients with migraine.

LANCET (2021)

Article Anesthesiology

Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine

Mohammad Al-Mahdi Al-Karagholi et al.

Summary: This study found that BKCa channel opening may trigger migraine attacks, and BKCa channel blockers could be potential candidates for novel antimigraine drugs.
Article Clinical Neurology

PACAP27 induces migraine-like attacks in migraine patients

Hashmat Ghanizada et al.

CEPHALALGIA (2020)

Review Medicine, General & Internal

Migraine

Messoud Ashina

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Clinical Neurology

Migraine and the trigeminovascular system-40 years and counting

Messoud Ashina et al.

LANCET NEUROLOGY (2019)

Article Clinical Neurology

K-ATP channel openers in the trigeminovascular system

K. B. Ploug et al.

CEPHALALGIA (2012)

Article Biochemistry & Molecular Biology

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Potently Dilates Middle Meningeal Arteries: Implications for Migraine

Arsalan U. Syed et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2012)

Article Neurosciences

Mechanisms of VIP-induced inhibition of the lymphatic vessel pump

Pierre-Yves von der Weid et al.

JOURNAL OF PHYSIOLOGY-LONDON (2012)

Article Pharmacology & Pharmacy

Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat

Michael Baun et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2011)

Article Clinical Neurology

PACAP38 induces migraine-like attacks in patients with migraine without aura

Henrik Winther Schytz et al.

Article Endocrinology & Metabolism

Location and function of VPAC(1), VPAC(2) and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries

S Grant et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)